Yayın:
Kinin Receptors and Their Antagonists as Novel Therapeutic Agents

dc.contributor.authorYusuf Öztürk
dc.contributor.authorÖZTÜRK, YUSUF
dc.contributor.orcid0000-0002-9488-0891
dc.date.accessioned2025-11-13T10:34:31Z
dc.date.issued2001-01-01
dc.identifier.doihttps://doi.org/10.2174/1381612013398338
dc.identifier.endpage161
dc.identifier.issn1381-6128
dc.identifier.issue2
dc.identifier.openalexW2145996184
dc.identifier.startpage135
dc.identifier.urihttps://hdl.handle.net/11421/4585
dc.identifier.urihttps://doi.org/10.2174/1381612013398338
dc.identifier.volume7
dc.language.isoen
dc.relation.ispartofCurrent Pharmaceutical Design
dc.rightsrestrictedAccess
dc.subjectKinin
dc.subjectReceptor
dc.subjectB2 receptor
dc.subjectInflammation
dc.subjectG protein-coupled receptor
dc.subjectMedicine
dc.subjectPharmacology
dc.subjectNeuroscience
dc.subjectImmunology
dc.subjectBradykinin
dc.subjectBiology
dc.subjectInternal medicine
dc.subject.sdg3
dc.titleKinin Receptors and Their Antagonists as Novel Therapeutic Agents
dc.typereview
dspace.entity.typePublication
local.authorid.openalexA5012641576

Dosyalar

Koleksiyonlar